EPCAM and neoplasm: The I2 estimate revealed no heterogeneity (I2 = 0%) among the studies, and the fixed effect model used in the meta-analysis indicated that expression of EpCAM in the tumour size >5 cm group was greater than that in the tumour size ≤ 5 cm group.